Cyrix Annual Report

Cyrix Corporation and Subsidiaries Notes to Consolidated Financial Statements

December 31, 1995

Note 1. Significant Accounting Policies

Description of the Business

Cyrix Corporation ("the Company") is engaged principally in the design, development, and marketing of high-performance advanced processors for IBM compatible personal computers which it sells principally through its direct sales force, independent representatives and distributors. Manufacturing of products is performed primarily through subcontractors.

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Cyrix International, Ltd., Cyrix Asia Pacific (Singapore) Pte. Ltd., Cyrix K.K., Cyrix International Inc. and Cyrix Manufacturing Inc. All significant intercompany accounts and transactions have been eliminated. Realized and unrealized foreign exchange gains and losses, which have not been material, have been included in results of operations.

Fiscal Year

The Company's fiscal year ends on a Sunday on or about December 31. Fiscal year 1995, a 52-week year, ended December 31, 1995. Fiscal years 1993 and 1994 ended January 2, 1994, and January 1, 1995, respectively. The accompanying financial statements have been labeled as though the Company's accounting periods end on the respective calendar year-end.

Reclassifications

Certain reclassifications of the financial statements for prior years have been made to conform to the 1995 presentation.

Investments

Investments are carried at cost, which approximates market. Investments consist primarily of commercial paper, municipal bond funds, government agency securities, corporate obligations, and money market funds. The Company considers all highly liquid investments with insignificant interest rate risk and original maturities of three months or less to be cash equivalents.

Inventories

Inventories are stated at the lower of standard cost, which approximates actual cost, determined on a first-in, first-out basis, or market. Inventories are stated net of lower of cost or market allowances of $14.7 million and $4.4 million as of December 31, 1995 and 1994, respectively. Inventories consist of the following at December 31:

Table: See the graphical version.

Management estimates the allowance required to state inventory at the lower of cost or market. During the fourth quarter of fiscal 1995, the average selling prices of 486DX2 microprocessors fell below the Company's cost to purchase these products, and the demand for these products declined substantially compared to prior quarters. As the Company does not expect to produce any or generate any significant revenue by selling 486 microprocessors in 1996, the Company wrote off substantially all of its 486 inventory, which exceeded $10 million, during the fourth quarter of fiscal 1995. As product life cycles become shorter and more difficult to predict, and price changes and transitions to new products become more rapid, there is a risk that the Company will forecast demand for its products and market conditions incorrectly and produce excess inventories. Therefore, there can be no assurance that the Company will not produce excess inventories and unexpectedly incur inventory lower of cost or market charges in the future.

Property and Equipment

Property and equipment are carried at cost. Depreciation is provided using the straight-line method over the estimated useful lives of the related assets or the term of the lease, if shorter, for assets recognized pursuant to capitalized leases.

The Company has purchased $88 million of wafer fabrication equipment which has been installed in an IBM facility. Management currently anticipates that such equipment has a five year useful life. Intel, the dominant company in the IBM compatible processor market, has a strategy to maintain its competitive advantage through aggressive investments in advanced manufacturing capacity. To remain competitive with Intel, the Company could be required to purchase and transition to more advanced manufacturing equipment before the time period in which its existing wafer fabrication equipment is fully depreciated. If the Company's equipment becomes obsolete as it relates to the manufacture of competitive microprocessors and the Company does not develop an alternative use for such equipment or is not able to sell the equipment for its net book value, the Company would incur a loss related to such equipment.

Revenue Recognition

Sales are recognized upon shipment to distributors and to original equipment manufacturer ("OEM") customers. Sales and receivables are reduced for estimated uncollectible accounts, estimated returns from OEM customers and estimated future price allowances to be granted to certain OEM customers. Sales to certain distributors are made under distributor agreements which provide the distributors certain rights of return and price protection on unsold merchandise held by the distributors. Accordingly, sales are reduced for estimated returns from distributors and estimated future price reductions of unsold merchandise held by distributors.

Royalty Revenue

Royalty revenue based on the sale by third-party licensees of licensed products is recognized by the Company upon fulfillment of its contractual obligations and determination of a royalty amount based on units sold. Pursuant to a November 1994 agreement, which settled a contractual dispute with Texas Instruments Incorporated ("TI"), on March 1, 1995 TI paid $15 million to the Company for past royalties and a fully paid-up license related to the Company's 486DLC and 486SLC microprocessor products. Royalty revenue for fiscal 1995 also included $2.7 million received from TI based upon sales of 486DX2 products licensed by the Company. No royalty revenue related to the sale by third-party licensees of licensed products was recognized in fiscal 1994 due to the contractual dispute with TI. Royalty revenue of $6.7 million was recognized in fiscal 1993.

Valuation Allowances

Valuation allowances related to net product sales consist of the following at December 31: Table: See the graphical version.

Management estimates the allowance for uncollectible accounts receivable. The Company performs on-going credit evaluations of its customers and requires advanced payments or secures transactions when deemed necessary. To date, the Company's credit losses have been within management's expectations. However, due to potential consolidation in the personal computer industry and unanticipated changes in the financial condition of the Company's customers, credit losses could exceed management's expectations in the future.

Sales to certain OEM customers and distributors are made under agreements which provide such customers certain rights of return and price protection on unsold merchandise. Management estimates the Company's allowance for returns from and price allowances to be granted to OEM customers and distributors. To date, returns from and price allowances granted to OEM customers and distributors have been within management's expectations. However, there can be no assurance that the Company will not have unanticipated returns or grant unexpected pricing allowances if a product does not perform to expectations, competitors reduce the price of products which are comparable to the Company's products beyond management's expectations, an OEM customer or distributor decides to discontinue its product line which uses Cyrix's products, or other unexpected circumstances occur.

Research And Development

Research and development costs are charged to operations when incurred.

Accounting for Stock Options

The Company grants stock options for a fixed number of shares to employees and directors with an exercise price equal to the fair value of the shares at the date of grant. The Company does not expect any financial impact related to Statement of Financial Accounting Standards No. 123, Accounting for Stock-Based Compensation, as the Company will continue to account for stock option grants in accordance with APB Opinion No. 25, Accounting for Stock Issued to Employees, and, accordingly, will recognize no compensation expense for the stock option grants.

Net Income per Common and Common Equivalent Share

Net income per common and common equivalent share were computed by dividing net income by the weighted average number of shares of common stock and common stock equivalents outstanding during each period. Convertible preferred stock, preferred stock options, preferred stock warrants, common stock options, and common stock warrants are common stock equivalents. The dilutive effects of common stock equivalents are calculated using the treasury stock method. Fully diluted net income per share is substantially the same as primary net income per share.

Warranty

Management estimates the allowance for warranty liability. Depending upon the customer, the Company offers warranties for all of its products, the terms of which the Company believes are standard for the industry. Under such warranties, the Company may be obligated to replace defective products and products that do not perform to applicable industry standards or to refund the purchase price of any such products. Further, the Company could be obligated to recall a product that does not perform to applicable industry standards. To date, warranty claims have been immaterial; however, there can be no assurance that future warranty claims will not have a material adverse effect on the Company's business and results of operations.

Estimates

Preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from the assumptions used by management in preparation of the financial statements.

| 10-K Contents | Page Top |

Note 2. Long-Term Obligations

The Company has certain debt agreements that contain provisions regarding restrictions on cash dividends and certain other transactions and the maintenance of certain net income per quarter, net worth, working capital and other financial ratios. Long-term debt and capitalized lease obligations consist of the following at December 31:

Note: If you wish, you can download the annual report in PDF format.

Table: See the graphical version.

As a result of the Company's financial performance during the fourth quarter of fiscal 1995, the Company failed to comply with certain quarterly restrictive covenants due to its failure to have positive net income and its failure to satisfy certain fixed charge coverage ratios. Each of the Company's creditors waived these defaults for the quarter ended December 31, 1995 and have agreed not to accelerate the maturity of any debt owed at the present time as a result of these defaults. However, certain lenders have declined for the present time to complete the funding of approximately $4 million for equipment purchases, which represents the balance of their commitment to the Company; therefore, the Company intends to fund such remaining equipment purchases from its current cash balances.

In fiscal 1994, the Company signed agreements with IBMCC and GECC ("the equipment lenders") whereby the $88 million capital equipment investment required by the Company's agreement with IBM is being financed under loans which require periodic principal and interest payments and will mature on the earlier of five years from the commencement of each loan or December 31, 1999. The interest rate for each loan is the average of the interest rates for three and five year U.S. Treasury Notes on specified dates plus three hundred twenty-nine basis points. The equipment which is financed by each loan serves as the primary collateral for such loan. In addition, the equipment lenders have a secondary security interest in substantially all of the Company's other assets. The financing agreements contain restrictive covenants which include restriction on dividends, additional debt and certain other transactions and include the maintenance of certain net worth, net income per quarter, working capital and other financial ratios.

The Company has a bank line of credit for up to $37.5 million which expires on January 3, 1997. Availability of the line of credit is subject to borrowing base requirements and compliance with loan covenants and restrictions which are similar to the covenants and restrictions in the equipment financing agreements. Outstanding advances are subject to interest at the Company's option, at either the bank's base rate, payable quarterly, or at 137.5 to 175 basis points over the bank's eurodollar interest rate, payable when each eurodollar advance matures. Collateral for the line of credit includes substantially all of the Company's assets other than the equipment financed by the equipment lenders as described above. Due to the Company's failure to comply with certain financial covenants, no borrowing was available under the line of credit as of December 31, 1995. The Company's line of credit lender issued a waiver of these covenant violations that allows the Company to draw on the line of credit subject to borrowing base requirements and cash flow based borrowing restrictions. There were no borrowings against the credit facility at any time during fiscal 1995.

For each of the next five years and beyond, long-term debt and capital lease obligations are payable as follows:

Table: See the graphical version.

Interest paid by the Company related to its notes payable during 1995, 1994 and 1993 amounted to $6.2 million, $554 thousand and $262 thousand, respectively. Of the total payments under capital leases in fiscal 1995, 1994 and 1993, $244 thousand, $230 thousand and $183 thousand, respectively, represented interest.

Assets under capital lease agreements were as follows at December 31:

Table: See the graphical version.

The Company leases office space and equipment under operating leases. Total rent expense for the fiscal years ended December 31, 1995, 1994, and 1993, was $2.0 million, $1.2 million and $1.6 million, respectively. Minimum rental commitments under noncancelable operating leases are as follows:

Table: See the graphical version.

| 10-K Contents | Page Top |

Note 3. Income Taxes

Income (Loss) Before Provision for Income Taxes by Geographic Operation

Table: See the graphical version.

Provision for Income Taxes

The Company uses Statement of Accounting Standards (SFAS) No. 109, "Accounting for Income Taxes," in computing income tax amounts. The provision for income tax expense consists of the following:

Table: See the graphical version.

Included in the current tax provisions reflected above are $1.7 million, $1.9 million and $0.6 million for 1995, 1994, and 1993, respectively, of tax benefits related to stock options exercised and disqualifying dispositions recorded as credits to stockholders' equity.

The provision for income taxes reconciles to the amount computed by applying the statutory U.S. federal rate of 35% to income before provision for income taxes as follows:

Table: See the graphical version.

No provision has been made for income taxes on approximately $2.5 million of cumulative undistributed earnings of certain foreign subsidiaries because it is the Company's intention to permanently reinvest such earnings. If such earnings were distributed, the estimated related taxes due, after giving effect to available tax credits, would be approximately $414 thousand.

The Company made income tax payments of $15.1 million in 1995, $19.6 million in 1994, and $13.2 million in 1993.

Analysis of Deferred Tax Assets (Liabilities)

Under SFAS No. 109, deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company's deferred tax assets and liabilities consisted of the following at December 31:

Table: See the graphical version.

At December 31, 1995 and 1994, no valuation allowance was recorded to offset deferred tax assets.

It is management's expectation that the deferred tax assets will be recoverable through the generation of future taxable income from ordinary and recurring operations. However, if future taxable income is not generated, the majority of the deferred tax assets would be recoverable by a carryback refund of taxes paid in the current or prior years. It is more likely than not that the remainder of the deferred tax assets will be realized.

| 10-K Contents | Page Top |

Note 4. Stockholders' Equity

Initial Public Offering

In July 1993, the Company and selling stockholders completed an initial public offering of 2,200,000 and 100,000 shares of the Company's common stock, respectively, and the Company received net proceeds of $32.1 million.

Series A Preferred Stock

As of December 31, 1995, 20,000,000 shares of Series A Convertible Preferred Stock were authorized, but none were outstanding. All outstanding Series A Preferred Stock were converted into common stock upon the closing of the Company's initial public offering in July 1993 at a conversion rate of one share of preferred stock for one share of common stock.

Series A Preferred Stock Warrants

Warrants to purchase 1,064,164 shares of Series A Preferred Stock at an exercise price of $0.40 per share were issued to an investor group in January 1990. All of the warrants were exercised prior to the closing of the Company's initial public offering in July 1993.

Series A Preferred Stock Options

During 1990, the Company granted options to consultants to purchase 213,799 shares of Series A Preferred Stock at $0.40 per share. All of the stock options were exercised prior to the closing of the Company's initial public offering in July 1993.

Common Stock Warrants

In conjunction with an equipment lease, on May 31, 1988, the Company issued the lessor warrants to purchase up to an aggregate of 180,178 shares of the Company's common stock at $0.40 per share. As partial consideration for obtaining a second equipment lease commitment, the Company issued a warrant to purchase up to 67,385 shares of the Company's common stock at $2.00 per share. All of these warrants were exercised prior to the closing of the initial public offering in July 1993.

1988 Incentive Stock Plan

The Company's 1988 Incentive Stock Plan, as amended ("the Plan"), provides for reservation, restriction, and issuance of 6,218,334 shares of common stock to employees, officers, directors, and consultants of the Company. The Plan provides for issuance of common stock upon the exercise of stock options and stock purchase rights, which may be granted under the Plan with exercise prices not less than the fair market value of the common stock on the date of grant. The proceeds received by the Company upon the exercise of stock options and stock purchase rights increase the Company's cash and equity balances. Stock option transactions during fiscal years 1993, 1994 and 1995 were as follows:

Table: See the graphical version.

The shares issued are subject to a repurchase option in favor of the Company of unvested shares upon discontinued employment. Shares issued generally vest over and are fully vested four years from the date of grant. At December 31, 1995, options to purchase 1,251,965 shares were exercisable and 1,139,737 shares were available for future grants.

Employee Stock Purchase Plan

On May 12, 1993, the Company adopted its Employee Stock Purchase Plan ("the Employee Stock Purchase Plan"), which provides for reservation and issuance of 200,000 shares of the Company's common stock. On April 27, 1995, 300,000 additional shares were added to the plan for a total of 500,000 shares. Eligible employees may purchase common stock through payroll deductions, which may not exceed 10% of an employee's base salary. The purchase price of the shares under the Employee Stock Purchase Plan is the lesser of 85% of the fair market value at the commencement of the purchase period or 85% of the fair market value on the last day of the purchase period. Each purchase period is six months. During fiscal 1995 and 1994, 54,867 and 39,903 shares of stock, respectively, were issued to employees under the Employee Stock Purchase Plan for an aggregate purchase price of $915 thousand and $687 thousand. No shares were issued under the Employee Stock Purchase Plan prior to fiscal 1994.

Non-Employee Directors Stock Plan

On April 27, 1995 the stockholders approved the Non-Discretionary Non-Employee Directors Stock Plan ("the Non-Employee Directors Stock Plan"), which provides for the issuance of 200,000 shares of common stock to non-employee directors of the Company based upon their service to the Company during the preceding year. The plan provides for issuance of common stock upon the exercise of stock options, which are granted with an exercise price equal to the fair market value of the common stock on the date of grant. During 1995, 35,000 options were granted to non-employee directors at an option price of $26.25, fair market value of the stock on the date of the grant. At December 31, 1995, no options were available for exercise and 165,000 shares were available for future grant.

| 10-K Contents | Page Top |

Note 5. Contingencies

Microprocessor Litigation

Since March 1992, the Company and Intel Corporation ("Intel") have been engaged in litigation related to certain of the Company's microprocessor products. On January 21, 1994, the United States District Court for the Eastern District of Texas, Sherman Division ruled in favor of the Company with respect to microprocessor products which were made and sold to the Company by certain Intel licensees, SGS-Thomson Microelectronics, Inc. ("SGS") and TI. Intel appealed the ruling on April 8, 1994. On December 8, 1994, the Court of Appeals for the Federal Circuit affirmed the district court's January 21, 1994 ruling. On December 23, 1994, Intel filed a petition for reconsideration of that decision and a motion for rehearing en banc with the Court of Appeals. In February 1995, the Court of Appeals for the Federal Circuit denied Intel's motion for a rehearing en banc.

On January 24, 1994, the United States District Court for the Eastern District of Texas, Sherman Division began to try the Company's allegations that Intel violated certain antitrust statutes and misused its patents and Intel's allegations that the Company infringed certain Intel patents. Effective January 31, 1994, the Company and Intel entered into a settlement agreement which provides for the dismissal of the claims which were to be litigated in the January 24, 1994 trial. Pursuant to the settlement agreement, Intel granted the Company a fully paid-up, irrevocable license under claims 2 and 6 of Intel's United States patent 4,972,338 ("the Crawford patent") and certain other system patents for products sold after January 31, 1994. Intel also acknowledged that products purchased by the Company from certain licensees exhaust Intel device claims including claim 1 of the Crawford patent. Further, Intel paid $5 million to the Company. The Company and Intel agreed that if the January 21, 1994 ruling, insofar as it relates to SGS, was reversed after final adjudication or was remanded for additional findings and subsequently reversed so that Cyrix did not have a right to use claims 2 and 6 of the Crawford patent based on the SGS license, Cyrix would return the $5 million plus interest to Intel. Cyrix deferred recognition as income of the $5 million settlement payment received in February 1994 until final resolution of this issue. Intel agreed to pay the Company an additional $5 million if the January 21, 1994 SGS ruling was upheld after final adjudication. As noted previously, in December 1994, the Court of Appeals for the Federal Circuit upheld the district court's January 21, 1994 ruling and later denied Intel's motion for a rehearing en banc. The time period during which Intel had the right to appeal the case to the United States Supreme Court expired without such appeal, and the Company received the additional $5 million settlement payment in the second quarter of 1995. Therefore, the Company recognized settlement income of $10 million in the second quarter of 1995.

As part of the settlement agreement, the Company and Intel agreed to litigate in the United States District Court for the Eastern District of Texas, Sherman Division, whether products manufactured by SGS affiliates under the "have-made" provision in the SGS-Intel license, sold to SGS, and then sold to the Company fall within the scope of the SGS license. On December 30, 1994, the district court ruled that SGS was licensed by Intel to exercise have-made rights by having third parties (including SGS affiliates) manufacture and sell microprocessors to Cyrix free of claims of patent infringement by Intel. Intel appealed the ruling on March 7, 1995. If the Company wins this licensing issue after all appeals have been exhausted, Intel will pay the Company $1 million. If Intel wins this licensing issue after final adjudication, the Company will pay Intel $1 million. The Company will have no liability to Intel for products manufactured by SGS affiliates prior to August 31, 1994, other than the potential $1 million payment, and will only have liability, if any, for products manufactured by SGS affiliates after August 31, 1994.

Similarly, the Company and Intel agreed to litigate in the United States District Court for the Eastern District of Texas, Sherman Division, whether IBM is licensed under claim 1 of the Crawford patent when manufacturing products that are primarily designed by the Company. On April 5, 1994, the district court granted IBM's motion to intervene, and on December 8, 1994, the district court ruled that IBM was licensed by Intel to act as a semiconductor foundry for Cyrix free of claims of patent infringement by Intel. Intel appealed the ruling on March 7, 1995. If the Company wins this licensing issue after final adjudication, Intel will pay the Company $1 million. If Intel wins this licensing issue after final adjudication, the Company will pay Intel $1 million. The Company will have no liability for products manufactured by IBM prior to January 31, 1994, other than the potential $1 million payment, and will only have liability, if any, for products manufactured by IBM after January 31, 1994.

Stockholders Class Action

In December 1994, eleven class actions were filed in the United States District Court for the Northern District of Texas, purportedly on behalf of purchasers of the Company's common stock, alleging that the Company and various of its officers and directors violated sections of the Securities and Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, by issuing false and misleading statements concerning the introduction and production of the Company's Cx486DX2 40/80 MHz microprocessors. The complaints also allege that the conduct of the Company and certain of its officers and directors constituted fraud and negligent misrepresentation.

In June 1995, all of the actions were consolidated into one complaint in the federal district court in Dallas, Texas. The Company intends to defend the complaint vigorously. The Company moved to dismiss the consolidated amended class action complaint in July 1995. The ultimate outcome of the stockholders class action cannot presently be determined. A decision adverse to the Company in this matter could have a material adverse effect on the Company, its financial condition, its results of operations and its future prospects.

Other Matters

The Company is a defendant in various other actions which arose in the normal course of business. In the opinion of management, the ultimate disposition of these other matters will not have a material adverse effect on the financial condition or overall trends in the results of operations of the Company.

| 10-K Contents | Page Top |

Note 6. Foreign Operations

The Company operates in one business segment, advanced processors. Operations outside the United States include both product testing and sales. A product test operation is located in Singapore and sales entities are located in the United Kingdom, Japan, Taiwan and Hong Kong. Generally, revenues between geographic areas are based on prevailing market prices or an approximation thereof. Identifiable assets are those associated with geographic area operations, excluding unallocated cash and short-term investments and internal company investments and receivables. A summary of the Company's operations by geographic area is presented below:

Note: If you wish, you can download the annual report in PDF format.

Table: See the graphical version.

Gross export sales to unaffiliated customers in Asia and the Pacific region by domestic operations in fiscal years 1995, 1994 and 1993 were $100 million, $53.8 million and $35.4 million, respectively. Also, gross export sales to unaffiliated customers in Europe by domestic operations in fiscal year 1995 were $44.1 million.

| 10-K Contents | Page Top |

Note 7. Disclosures about Fair Value of Financial Instruments

The following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practicable to estimate that value:

Cash and Cash Equivalents. The carrying amount approximates fair value.

Investments. The carrying amount approximates fair value because of the short maturity and nature of these instruments. The Company places its cash investments only in high credit quality financial instruments and limits the amount invested in any one institution or in any type of instrument. The Company has not experienced any significant losses on its investments.

Accounts Receivable. The carrying amount, which is net of valuation allowances for credit losses and returns from and price allowances to be granted to certain OEM customers, approximates fair value.

One customer, AST, accounted for approximately 11% of Cyrix's sales in fiscal 1995. The loss of such customer, if not replaced by other OEM customers with similar sales volumes, could have a material adverse effect on the Company's results of operations.

Accounts Payable. The carrying amount approximates fair value because of the short-term nature of these instruments.

Long-Term Debt and Capitalized Lease Obligations, Including Current Maturities. Of the Company's $82.4 million in long-term debt and capitalized lease obligations, approximately $64.1 million was borrowed in fiscal 1995 and remains outstanding at December 31, 1995. As the majority of the debt was incurred in 1995, the carrying amounts approximate fair value. The carrying amounts of long-term debt and capitalized lease obligations related to borrowings prior to fiscal 1995 do not differ materially from their fair values estimated using discounted future cash flows analysis and rates currently available for debt of similar terms and maturity.

| 10-K Contents | Page Top |

Note 8. Risks And Uncertainties

The Company's future results of operations and financial condition could be impacted by the following factors, among others: trends in the personal computer market, introduction of new products by competitors, delay in the Company's introduction of higher performance products, chip set, motherboard and BIOS infrastructure support for the Company's products, market acceptance of new products introduced by the Company, intense price competition, interruption in the supply of low-cost microprocessor products from third-party manufacturers, adverse changes in general economic conditions in any of the countries in which the Company does business and adverse decisions in legal disputes with Intel or others.

The Company's manufacturing strategy is to develop relationships with qualified semiconductor manufacturers which offer leading CMOS process technologies. The Company has focused its resources on product design, market development and customer support, rather than on developing process technologies and operating manufacturing facilities. Instead, the Company relies upon third parties to manufacture and assemble its products. The Company's reliance on third-party manufacturers causes several material risks, including the possible unavailability of or delays in obtaining access to certain process technologies, the absence of controllable product delivery schedules, manufacturing yields and production costs and the possible breakdown in the relationship with the third-party manufacturers. Any significant delay or production cost problem brought about by these risks could have a severe impact on the Company. For example, production of the 6x86 products is expected to ramp in the first quarter of fiscal 1996 at IBM and the third quarter of 1996 at SGS if SGS is capable of manufacturing that product with acceptable performance and cost. The Company's financial performance during fiscal 1996 will be dependent upon numerous factors including a successful transition from entry level microprocessors to the Company's 6x86 microprocessors, on-going performance enhancements to the 6x86 microprocessor design to remain competitive with the leading performance processors in the market, improved manufacturing yields by IBM, successful qualification of the SGS manufacturing process during the first half of fiscal 1996 and production ramp during the latter half of 1996, pricing conditions, obtaining design wins from manufacturers of personal computers and other factors. There can be no assurance that the Company and its suppliers can successfully supply 6x86 products with competitive performance and cost in commercial volumes during 1996. In addition, there can be no assurances that manufacturers of personal computers will design the 6x86 product into their computers or purchase such products in volumes and at prices that will enable Cyrix to maintain or increase revenues and profits. Further, Cyrix competitors could introduce more advanced or lower priced products that shorten the life cycle of, or the demand for, such 6x86 products which in turn could have a severe impact on the Company's future performance.

From time to time, Cyrix has been notified that it may infringe intellectual property rights of others. If any such claims are asserted against the Company, the Company may seek to obtain a license under the third-party's intellectual property rights. The Company could decide, however, to resort to litigation to challenge such claims. Such challenges could be extremely expensive and time consuming and could materially adversely affect the Company's business, financial condition and results of operations. No assurance can be given that all necessary licenses can be obtained on reasonable terms nor that litigation can be avoided. The Company's inability to obtain licenses on favorable terms or avoid litigation related to such licenses could have a severe impact on the future operations of the Company.